Profile data is unavailable for this security.
About the company
Thermo Fisher Scientific Inc. is engaged in accelerating life sciences research, solving complex analytical challenges, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. Through its Life Sciences Solutions segment, it provides a portfolio of reagents, instruments and consumables used in biological and medical research, the discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Through its Analytical Instruments segment, it provides instruments and the supporting consumables, software and services that are used for a range of applications. Its Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. Its Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory. It also provides purification and filtration technologies.
- Revenue in USD (TTM)44.56bn
- Net income in USD6.70bn
- Incorporated1960
- Employees125.00k
- LocationThermo Fisher Scientific Inc168 Third AvenueWALTHAM 02451United StatesUSA
- Phone+1 (781) 622-1000
- Fax+1 (781) 622-1207
- Websitehttps://corporate.thermofisher.com/us/en/index.html
Mergers & acquisitions
| Acquired company | TMO:NYQ since announced | Transaction value |
|---|---|---|
| Clario Inc | -2.65% | 9.40bn |
| Sanofi SA-Steriles Manufacturing Site | 29.87% | -- |
| Solventum Corp-Purification & Filtration Business | 1.36% | 4.10bn |
